Morgan Stanley is a leading global financial services firm that provides a wide range of services in investment banking, securities, wealth management, and investment management. Catering to a diverse clientele that includes corporations, governments, and individuals, Morgan Stanley offers expert advisory and financing services, helping clients navigate complex financial markets and achieve their financial objectives. The firm is known for its strategic insights, innovative solutions, and commitment to delivering exceptional service, positioning itself as a trusted partner in the world of finance. Read More
Morgan Stanley Investment Management today announced the upcoming liquidation of Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF (CDEI) (the Fund), a series of Morgan Stanley ETF Trust (the Trust). The Board of the Trust approved a Plan of Liquidation with respect to the Fund. Pursuant to the Plan of Liquidation, the assets of the Fund will be liquidated, known or reasonably ascertainable liabilities of the Fund will be satisfied or provided for, the remaining proceeds will be distributed to the Fund’s shareholders and all of the issued and outstanding shares of the Fund will be redeemed (the Liquidation). The Liquidation is expected to occur on or about November 2, 2026 (the Liquidation Date).
Financial providers use their expertise in capital allocation and risk assessment to help facilitate economic growth while offering consumers and businesses ...
Diamondback Energy shares fell after a Morgan Stanley downgrade and a large share block sale, but strong Q2 earnings and a persistent Middle East supply gap support a higher oil price floor.
Ingersoll Rand (NYSE:IR) executives said improving demand in short-, medium- and long-cycle businesses, combined with investments in commercial capabilities and engineered solutions, supported a more optimistic outlook for organic growth.
Speaking at a Morgan Stanley conference, Chairman, President
What Happened? Shares of cybersecurity platform provider CrowdStrike (NASDAQ:CRWD) jumped 4.5% in the afternoon session as it broke out to a fresh 52-week hi...
What Happened? Shares of cruise vacation company Royal Caribbean (NYSE:RCL) fell 3.9% in the afternoon session after the company said it will buy half of San...
ATI (NYSE:ATI) has transformed its portfolio toward aerospace and defense markets, with those end markets now representing about 70% of total revenue, President and CEO Kim Fields said during a Morgan Stanley aerospace and defense conference panel.
Fields said the company’s shift began in 2019, whe
Neurocrine Biosciences (NASDAQ:NBIX) outlined its commercial growth priorities, pricing considerations and pipeline plans during a Morgan Stanley discussion, with CEO Kyle Gano emphasizing the company’s efforts to diversify beyond its largest product, INGREZZA.
Gano said China has become both a com
What Happened? A number of stocks fell in the afternoon session after investors kept bidding the group lower after last week’s Federal Reserve hike. On Septe...
Compass Pathways (NASDAQ:CMPS) expects to complete its new drug application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth quarter, with a potential U.S. launch in the first half of 2027, executives said at the Morgan Stanley Global
Abeona Therapeutics (NASDAQ:ABEO) executives outlined the early commercial rollout of ZEVASKYN, an autologous cell sheet-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), during the Morgan Stanley Global Healthcare Conference. Management emphasized that the launch requires a
Tempus AI (NASDAQ:TEM) Founder and CEO Eric Lefkofsky said the company’s second-quarter performance was supported by continued demand for comprehensive genomic profiling and growth in its data-licensing business.
Speaking at Morgan Stanley’s Global Healthcare Conference, Lefkofsky said the diagnost
